SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Convertible Notes Payable
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Convertible Notes Payable of $10.00 million as of 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Balance Sheet › Liabilities › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2026-03-31
- 2025-06-30: Convertible Notes Payable $10.00M.
- 2025-03-31: Convertible Notes Payable $10.00M.
- 2024-12-31: Convertible Notes Payable $10.00M.
- 2024-09-30: Convertible Notes Payable $10.00M.
| Period end | Convertible Notes Payable |
|---|---|
| 2025-06-30 | $10.00M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $10.00M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $10.00M 10-K · filed 2025-02-26 |
| 2024-09-30 | $10.00M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $10.00M 10-Q · filed 2024-09-04 |
| 2024-03-31 | $10.00M 10-Q/A · filed 2024-09-04 |
| 2023-12-31 | $10.00M 10-K/A · filed 2024-09-04 |
| 2023-09-30 | $10.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $10.00M 10-Q · filed 2023-08-14 |
| 2023-01-11 | $10.00M 10-K · filed 2026-03-31 |
| 2022-08-01 | $125.00K 10-K · filed 2023-03-15 |
| 2022-03-11 | $224.99K 10-K · filed 2023-03-15 |
| 2022-02-08 | $365.00K 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |